Understanding your genetic profile should be interpreted with a qualified healthcare provider and does not predict exact medication response
Research suggests that some people may regain weight after stopping Wegovy

Avoid this treatment if: You have been diagnosed with type 1 diabetes You are pregnant, trying to become pregnant, or breastfeeding You have severe digestive conditions, including gastroparesis (delayed stomach emptying) You have an allergy to tirzepatide or any ingredient listed in the medication You are under 18 You should also speak to a healthcare professional before starting Mounjaro if you have any of the following, as extra caution or monitoring may be needed: A history of pancreatitis Gallbladder problems, including gallstones Significant kidney disease or dehydration risk (especially if you are prone to vomiting) Liver problems Diabetic eye disease (diabetic retinopathy), particularly if your blood sugars may change quickly A history of severe allergic reactions to injectable medicines You take other diabetes medications, especially insulin or sulfonylureas, as your risk of low blood sugar may be higher As with any prescription weight loss treatment, ongoing monitoring is important

10.1002/jobm.3620350404
Lab recommendations for patients taking GLP1-RAs typically include regular monitoring of blood glucose levels and hemoglobin A1c (HbA1c), a measure of average blood glucose levels over the past 2-3 months
Ali commented that this studys findings align with his clinical experiences